Unknown

Dataset Information

0

Digital symbol-digit modalities test with modified flexible protocols in patients with CNS demyelinating diseases.


ABSTRACT: Cognitive impairment (CI) is prevalent in central nervous system demyelinating diseases, such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). We developed a novel tablet-based modified digital Symbol Digit Modalities Test (MD-SDMT) with adjustable protocols that feature alternating symbol-digit combinations in each trial, lasting one or two minutes. We assessed 144 patients (99 with MS and 45 with NMOSD) using both MD-SDMT protocols and the traditional paper-based SDMT. We also gathered participants' feedback through a questionnaire regarding their preferences and perceived reliability. The results showed strong correlations between MD-SDMT and paper-based SDMT scores (Pearsons correlation: 0.88 for 2 min; 0.85 for 1 min, both p < 0.001). Among the 120 respondents, the majority preferred the digitalized SDMT (55% for the 2 min, 39% for the 1 min) over the paper-based version (6%), with the 2 min MD-SDMT reported as the most reliable test. Notably, patients with NMOSD and older individuals exhibited a preference for the paper-based test, as compared to those with MS and younger patients. In summary, even with short test durations, the digitalized SDMT effectively evaluates cognitive function in MS and NMOSD patients, and is generally preferred over the paper-based method, although preferences may vary with patient characteristics.

SUBMITTER: Seo D 

PROVIDER: S-EPMC11199480 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Digital symbol-digit modalities test with modified flexible protocols in patients with CNS demyelinating diseases.

Seo Dayoung D   So Jeong Min JM   Kim Jiyon J   Jung Heejae H   Jang Inhye I   Kim Hyunjin H   Kang Dong-Wha DW   Lim Young-Min YM   Choi Jaesoon J   Lee Eun-Jae EJ  

Scientific reports 20240625 1


Cognitive impairment (CI) is prevalent in central nervous system demyelinating diseases, such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). We developed a novel tablet-based modified digital Symbol Digit Modalities Test (MD-SDMT) with adjustable protocols that feature alternating symbol-digit combinations in each trial, lasting one or two minutes. We assessed 144 patients (99 with MS and 45 with NMOSD) using both MD-SDMT protocols and the traditional paper-based  ...[more]

Similar Datasets

| S-EPMC4120763 | biostudies-literature
| S-EPMC7904910 | biostudies-literature
| S-EPMC6826875 | biostudies-literature
| S-EPMC7573704 | biostudies-literature
| S-EPMC8507906 | biostudies-literature
| S-EPMC8226371 | biostudies-literature
| S-EPMC7504980 | biostudies-literature
| S-EPMC7542403 | biostudies-literature
| S-EPMC9919459 | biostudies-literature
| S-EPMC10590153 | biostudies-literature